Types of Hyperparathyroidism
Hyperparathyroidism is classified into three distinct types—primary, secondary, and tertiary—each defined by unique pathophysiology, biochemical profiles, and underlying causes. 1, 2
Primary Hyperparathyroidism
Primary hyperparathyroidism results from autonomous parathyroid gland overproduction of PTH, causing hypercalcemia with elevated or inappropriately normal PTH levels. 1, 2
Key biochemical features:
- Elevated serum calcium with elevated or inappropriately normal PTH 1, 2
- Low or low-normal serum phosphate 1
- Hypercalciuria (>250-300 mg/day) in most patients due to increased filtered calcium load 1
Etiologies:
- Single parathyroid adenoma accounts for approximately 80% of cases, making it the most common cause 1, 2
- Multigland disease (hyperplasia) affects 15-20% of patients 1, 2
- Parathyroid carcinoma is rare, occurring in less than 1% of cases 1, 2
The pathophysiology involves autonomous PTH secretion independent of normal calcium feedback mechanisms, distinguishing it fundamentally from secondary hyperparathyroidism. 1
Secondary Hyperparathyroidism
Secondary hyperparathyroidism represents a compensatory physiologic response where elevated PTH attempts to correct calcium homeostasis but fails due to underlying organ dysfunction or reduced calcium availability. 3, 1
Key biochemical features:
- Normal or low serum calcium with elevated PTH 1, 4
- Hyperphosphatemia (>4.6 mg/dL in CKD stages 3-4, or >5.5 mg/dL in stage 5) 1
- Elevated alkaline phosphatase suggesting high bone turnover 1
Primary drivers and causes:
- Chronic kidney disease is the most common cause, as declining renal function leads to phosphate retention, decreased calcitriol production, and impaired calcium absorption 3, 1
- Vitamin D deficiency (25(OH)D <30 ng/mL) 1
- Malabsorption syndromes 3, 1
The critical distinction is that PTH elevation is appropriate and responsive to the underlying stimulus (hypocalcemia, hyperphosphatemia, or vitamin D deficiency), not autonomous. 1, 5
Tertiary Hyperparathyroidism
Tertiary hyperparathyroidism develops when parathyroid glands become autonomously hypersecreting after prolonged stimulation from longstanding secondary hyperparathyroidism, losing their normal feedback regulation. 3, 1, 2
Key biochemical features:
- Hypercalcemia with elevated PTH 1, 2, 5
- PTH remains elevated despite rising serum calcium levels, representing autonomous hypersecretion 3, 1
Clinical context:
- Most commonly encountered following kidney transplantation in patients with long-standing chronic kidney disease 3, 1, 2
- Typically involves multigland disease (parathyroid hyperplasia) 3, 1
The pathophysiology reflects progression from compensatory to autonomous PTH production, where the glands no longer respond appropriately to calcium feedback. 2, 5
Diagnostic Algorithm Summary
| Feature | Primary HPT | Secondary HPT | Tertiary HPT |
|---|---|---|---|
| Calcium | Elevated | Normal or low | Elevated |
| PTH | Elevated or inappropriately normal | Elevated | Elevated |
| Pathophysiology | Autonomous secretion | Compensatory response | Autonomous after chronic stimulation |
| Common Cause | Adenoma (80%) | Chronic kidney disease | Post-transplant CKD |
Critical Clinical Pitfalls
Vitamin D deficiency must always be assessed, as it can complicate interpretation of PTH levels in all types of hyperparathyroidism and can mask hypercalciuria in primary hyperparathyroidism. 1, 4
Different PTH assay generations measure different PTH fragments and can yield significantly different values, requiring use of assay-specific reference ranges. 1, 4
Imaging has no role in confirming or excluding the diagnosis of hyperparathyroidism—diagnosis is purely biochemical, and imaging is used only for lesion localization after biochemical diagnosis is established. 1, 4